Gujarat Themis Biosyn Limited (BOM:506879)

Gujarat Themis Biosyn Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	1,593	1,508	1,698	1,484	1,149	905.63
Revenue Growth (YoY)	2.74%	-11.20%	14.45%	29.20%	26.82%	6.39%
Cost of Revenue	600.09	593.2	687.4	573.39	181.25	168.27
Gross Profit	993.18	914.8	1,011	910.46	967.29	737.36
Selling, General & Admin	170.5	137.35	128.68	89.42	71.99	74.2
Other Operating Expenses	91.95	80.38	95.04	76.04	307.64	249.14
Operating Expenses	363.54	271.47	259.08	191.22	401.96	340.66
Operating Income	629.64	643.33	751.75	719.25	565.33	396.7
Interest Expense	-9.83	-2.33	-1.43	-0.95	-6.56	-5.25
Interest & Investment Income	7.12	7.12	40.35	51.29	32.61	21.51
Currency Exchange Gain (Loss)	0.53	0.53	0.23	-	0.09	-
Other Non Operating Income (Expenses)	10.95	6.73	2.45	5.06	-1.13	-4.26
EBT Excluding Unusual Items	638.41	655.38	793.34	774.65	590.35	408.7
Gain (Loss) on Sale of Assets	-	-	-	-	-	0.12
Pretax Income	638.41	655.38	793.34	774.65	590.35	408.82
Income Tax Expense	160.52	167.66	201.71	194.96	154.1	107.02
Net Income	477.89	487.72	591.63	579.69	436.24	301.8
Net Income to Common	477.89	487.72	591.63	579.69	436.24	301.8
Net Income Growth	-9.25%	-17.56%	2.06%	32.88%	44.55%	27.48%
Shares Outstanding (Basic)	109	109	109	109	109	109
Shares Outstanding (Diluted)	109	109	109	109	109	109
EPS (Basic)	4.39	4.48	5.43	5.32	4.00	2.77
EPS (Diluted)	4.39	4.48	5.43	5.32	4.00	2.77
EPS Growth	-9.13%	-17.56%	2.06%	32.88%	44.57%	27.46%
Free Cash Flow	-	-251.22	-104.32	157.74	264.16	74.73
Free Cash Flow Per Share	-	-2.31	-0.96	1.45	2.42	0.69
Dividend Per Share	-	0.670	1.000	0.720	0.800	-
Dividend Growth	-	-33.00%	38.89%	-10.00%	-	-
Gross Margin	62.34%	60.66%	59.52%	61.36%	84.22%	81.42%
Operating Margin	39.52%	42.66%	44.27%	48.47%	49.22%	43.80%
Profit Margin	29.99%	32.34%	34.84%	39.07%	37.98%	33.32%
Free Cash Flow Margin	-	-16.66%	-6.14%	10.63%	23.00%	8.25%
EBITDA	684.01	684.61	775.58	737.48	580.14	414.03
EBITDA Margin	42.93%	45.40%	45.67%	49.70%	50.51%	45.72%
D&A For EBITDA	54.37	41.28	23.83	18.24	14.81	17.33
EBIT	629.64	643.33	751.75	719.25	565.33	396.7
EBIT Margin	39.52%	42.66%	44.27%	48.47%	49.22%	43.80%
Effective Tax Rate	25.14%	25.58%	25.42%	25.17%	26.10%	26.18%
Revenue as Reported	1,622	1,532	1,742	1,550	1,189	938.29
Advertising Expenses	-	0.07	0.16	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.